ATON SA (ALTAO.PA) Stock Price, Forecast & Analysis
Europe • Euronext Paris • EPA:ALTAO • FR0004153930
ALTAO.PA Key Statistics, Chart & Performance
The current stock price of ALTAO.PA is 0.006 EUR. In the past month the price decreased by -3.23%. In the past year, price decreased by -40.59%.
ALTAO.PA Technical Analysis
ALTAO.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALTAO.PA. ALTAO.PA has a bad profitability rating. Also its financial health evaluation is rather negative.
ALTAO.PA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -19.58% | ||
| ROE | -265.3% | ||
| Debt/Equity | 5.62 |
ALTAO.PA Forecast & Estimates
ALTAO.PA Ownership
ALTAO.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 28.2 | 44.346B | ||
| ARGX | ARGENX SE | 27.15 | 44.309B | ||
| 22UA | BIONTECH SE-ADR | N/A | 21.797B | ||
| ABVX | ABIVAX SA | N/A | 7.491B | ||
| 2X1 | ABIVAX SA | N/A | 7.46B | ||
| GLPG | GALAPAGOS NV | N/A | 1.885B | ||
| GXE | GALAPAGOS NV | N/A | 1.885B | ||
| IVA | INVENTIVA SA | N/A | 978.821M | ||
| 6IV | INVENTIVA SA | N/A | 978.821M | ||
| NANO | NANOBIOTIX | N/A | 877.756M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALTAO.PA
Company Profile
Aton SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies for the treatment of proliferative diseases. The company is headquartered in Illkirch-Graffenstaden, Grand Est and currently employs 9 full-time employees. The company went IPO on 2007-12-17. The company specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The firm is specialized in the research and development (R&D) of drugs to fight cancer. The company is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. The company operates through Hybrigenics Corporation and Imaxio.
Company Info
ATON SA
850 Boulevard Sebastien Brant
Illkirch-Graffenstaden GRAND EST FR
Employees: 9
Phone: 33972569499
ATON SA / ALTAO.PA FAQ
What does ATON SA do?
Aton SA operates as a biopharmaceutical company, which engages in the research and development of targets and therapies for the treatment of proliferative diseases. The company is headquartered in Illkirch-Graffenstaden, Grand Est and currently employs 9 full-time employees. The company went IPO on 2007-12-17. The company specializes in the research and development of drugs intended for cancer treatment and supplies scientific services in the protein interaction field. The firm is specialized in the research and development (R&D) of drugs to fight cancer. The company is organized in two units: Hybrigenics Pharma for internal R&D, which develops a research program aimed at such diseases as melanoma and prostate cancer; and Hybrigenics Services for commercial business, mainly engaged in protein interaction information and solutions. Hybrigenics SA’s main development program is based on inecalcitol, a vitamin D analogue, for prostate cancer treatment. The company operates through Hybrigenics Corporation and Imaxio.
Can you provide the latest stock price for ATON SA?
The current stock price of ALTAO.PA is 0.006 EUR.
Does ATON SA pay dividends?
ALTAO.PA does not pay a dividend.
What is the ChartMill rating of ATON SA stock?
ALTAO.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Is ATON SA (ALTAO.PA) stock a good buy?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALTAO.PA.